Her research interests include inflammation and immunity in cardiovascular thrombosis, as well as gene expression and extracellular RNAs as biomarkers and modulators of heart disease and stroke, the AHA said in a news release announcing her appointment.
Freedman has led numerous large research projects, given talks at universities and conferences around the world, and published more than 150 papers in leading medical journals, according to the AHA.
Freedman has served on the editorial board of Circulation Research since 1998 and was previously an associate and senior editor for the AHA’s flagship journal, Circulation. She’s also held several other editorial positions with leading cardiovascular research journals.
“I’m thrilled and honored to take on this role and I look forward to working with our new editorial board in broadening our scientific scope and having greater interface with early and mid-career scientist and even consumer audiences,” Freedman said in the release.
“I’m continually fascinated, learning new things every day as I read through the submitted studies and it’s exciting to know that the science we’re publishing today could likely be the practiced medical discoveries of tomorrow,” she added.
She replaces Roberto Bolli, MD, who was “relieved” of his position as editor of the AHA journal in March for comments alleged to be “hate speech,” as reported by theheart.org | Medscape Cardiology.
Looking to the Future
In describing her vision for the journal, Freedman said: “Circulation Research will continue to be the preeminent journal for the basic and translational cardiovascular and stroke research community. The new editorial team will solidify Circulation Research‘s position as the unequivocal leader in the ever-broadening field of the basic cardiovascular sciences. Our goal is to make Circulation Research the place to find and publish the highest impact and reliable research while promoting inclusively, quality, and integrity.”
Freedman said she envisions Circulation Research becoming a forum through greater interface with users. “In building our social media and online presence, we plan to go beyond simply presenting science by engaging our users through established models (e.g., Twitter), as well as journal clubs, Instagram, and podcasts.”
Engaging with early and mid-career investigators will remain a priority. “To survive and thrive, journals must remain relevant to a younger generation of scientists,” writes Freedman.
“We enthusiastically endorse the selection of Dr Freedman as the editor-in-chief of Circulation Research,” said Mark Estes, MD, chair of the AHA’s scientific publishing committee.
“Along with her editorial experience, she’s an active member of the association’s Arteriosclerosis, Thrombosis and Vascular Biology Council and is a highly respected investigator and clinician. She will work collaboratively with her outstanding editorial board with the full support of the AHA staff and the scientific publishing committee to ensure that Circulation Research remains the premier journal for publication of the best basic and translational science,” said Estes, professor of medicine, New England Cardiac Arrhythmia Center at Tufts University School of Medicine, Boston.